L'accident vasculaire cérébral en France : patients hospitalisés pour AVC en, p.11, 2008. ,
Mortalité par accident vasculaire cérébral en France en, p.6, 2008. ,
, National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke, N Engl J Med, vol.14, issue.24, pp.1581-1588, 1995.
Thrombolysis for acute ischaemic stroke, Cochrane Database Syst Rev, issue.3, p.213, 2003. ,
Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke, Stroke. mars, vol.38, issue.3, pp.948-54, 2007. ,
The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET), Stroke. févr, vol.41, issue.2, pp.295-304, 2010. ,
Revascularization results in the Interventional Management of Stroke II trial, AJNR Am J Neuroradiol. mars, vol.29, issue.3, pp.582-589, 2008. ,
A randomized trial of intraarterial treatment for acute ischemic stroke, N Engl J Med. 1 janv, vol.372, issue.1, 2015. ,
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials, Lancet Lond Engl. 23 avr, vol.387, pp.1723-1754, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01876049
Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients, Stroke. mai, vol.34, issue.5, pp.1235-1276, 2003. ,
Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients, Stroke. août, vol.36, issue.8, pp.1705-1714, 2005. ,
Leukoaraiosis as an outcome predictor in the acute and subacute phases of stroke, Expert Rev Neurother, vol.17, issue.10, pp.963-75, 2017. ,
Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke, J Neurol. juin, vol.255, issue.6, p.80, 2008. ,
, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis. Stroke, 2017.
Predictors for recanalization after intravenous thrombolysis in acute ischemic stroke, J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. févr, vol.16, issue.1, p.4, 2007. ,
The role of high-sensitivity C-reactive protein levels in functional outcomes in patients with large-artery atherosclerosis and small-artery occlusion, Neurol Res, 2017. ,
ASPECTS (Alberta Stroke Program Early CT Score) Assessment of the Perfusion-Diffusion Mismatch, Stroke, vol.47, issue.10, pp.2553-2561, 2016. ,
Significance of hyperintense vessels on FLAIR MRI in acute stroke, Neurology. 25 juill, vol.55, issue.2, p.9, 2000. ,
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging, AJR Am J Roentgenol. août, vol.149, issue.2, pp.351-357, 1987. ,
Intravenous thrombolysis outcomes in patients presenting with large vessel acute ischemic strokes--CT angiography-based prognosis, J Neuroimaging Off J Am Soc Neuroimaging. avr, vol.25, issue.2, p.42, 2015. ,
Thrombolysis for acute ischaemic stroke ,
, Cochrane Database Syst Rev, issue.4, p.213, 2009.
Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onset, Arch Med Sci AMS. 30 juin, vol.6, issue.3, pp.303-318, 2010. ,
Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST), Stroke. déc, vol.39, issue.12, pp.3316-3338, 2008. ,
Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome, JAMA, vol.292, issue.15, pp.1839-1883, 2004. ,
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials, Lancet Lond Engl, vol.29, issue.9958, p.35, 1929. ,
,
, Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive, BMJ, vol.23, p.6046, 2010.
Diabetes, hyperglycaemia, and acute ischaemic stroke, Lancet Neurol. mars, vol.11, issue.3, pp.261-71, 2012. ,
Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study, Ann Neurol. juill, vol.52, issue.1, pp.20-28, 2002. ,
Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis, Arterioscler Thromb J Vasc Biol. déc, vol.13, issue.12, pp.1822-1830, 1993. ,
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus, Arterioscler Dallas Tex. févr, 1988. ,
Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients--relationship with plasma insulin, Thromb Haemost. 30 juin, vol.61, issue.3, pp.370-373, 1989. ,
Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat, Acta Diabetol, vol.38, issue.2, pp.71-77, 2001. ,
The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke, Int J Stroke Off J Int Stroke Soc. févr, vol.9, issue.2, p.51, 2014. ,
, DEUXIEME PARTIE Article publié en anglais dans la revue Mathews Journal of Emergency Medicine, vol.16, 2018.
, Predictors of clinical Outcome after Intravenous Thrombolysis in Ischemic Stroke without Large Vessel Occlusion : The Role of Admission Glycemia